19/07/2025
Choose your practitioners wisely!
Too many people I speak to have no idea what products are used in their faces and haven’t been seen by a face to face prescriber
⚠️ Safety Alert: Iatrogenic Botulism Linked to Botulinum Toxin Injections
A number of cases of botulism have been reported in the UK following botulinum toxin injections. While rare, this condition can lead to serious complications including neurological symptoms and, in severe cases, respiratory compromise.
Key points for practitioners:
• Symptoms may appear up to 17 days post-treatment
• Signs include ptosis, double vision, slurred speech, swallowing difficulty, and muscle weakness
• Risk factors include unlicensed products, incorrect dilution, and systemic absorption
• Prompt recognition and early antitoxin treatment (within 48–96 hours) is critical
The full BAMAN briefing note has been emailed directly to members’ inboxes.
We thank the UK Health Security Agency (UKHSA) for contacting BAMAN directly to share this important information.
BAMAN will continue to update members with any further developments and safety communications as they arise.
Please remain vigilant and report any adverse events via the Yellow Card Scheme.
